Hearing loss as risk factor for dementia: in search of evidence. Med Int Méx 2024; 40 (11): 747-756. https://doi.org/10.24245/mim.v40iDiciembre.9417 Juan Antonio Lugo Machado, 1 Araceli Zazueta Cárdenas 2 1 Hospital de Especialidades Lic. Luis Donaldo Colosio…
Methylmethacrylate embolism. Med Int Méx 2024; 40 (2): 127-136. https://doi.org/10.24245/mim.v40i2.8182 Edward Jassir Rozo Ortiz,1,2 Javier Orlando Barón Barón,1,2 Karen Geraldine Torres Rodríguez,1 Jessica Alejandra Guerrero León,1 Leidy Rocío Palacios Rojas,1 Laura Stefanny López Niño,1 Sonia Elizabeth Reyes,1 Ledmar Jovanny…
Hidden curriculum in medical education: Concepts and dimensions. Scope review. Med Int Méx 2023; 39 (6): 883-898. https://doi.org/10.24245/mim.v39i6.7874 Juan Antonio Lugo Machado,1 José Aurelio Menéndez Cázares,2 Elizabeth Medina Valentón,1 Patricia Emiliana García Ramírez,1 José Alberto Guerrero…
Use of factor Xa/direct oral anticoagulants inhibitors compared to warfarin in obese patients. Med Int Méx 2023; 39 (4): 629-641. https://doi.org/10.24245/mim.v39i4.6965 Dennis Ximena Murcia Acero,1 Mónica Paola Quemba Mesa2 1 Residente de Ginecología y…
Tocilizumab, a cutting-edge therapeutic resource against SARS-CoV-2 infection: A scoping review. Med Int Méx 2023; 39 (1): 66-90. https://doi.org/10.24245/mim.v39i1.7847 Eduardo Tuta-Quintero,1 Claudia Mora-Karam,1 Julia Camacho-Osorio,1 Santiago Rhenals-Acuña,2 Francisco Arrieta-Acuña,2 Daniela Pérez-Mantilla,3 Nicolás Cristiano-Alvarado,4 Juan Pimentel1 1 Facultad de Medicina, Universidad…
Separation of blood components in patients critically ill with COVID-19. Med Int Méx 2022; 38 (4): 825-830. https://doi.org/10.24245/mim.v38i4.5846 Oscar A Peñuela-Briceño,1 Lina A Gómez2 1 MSL Field Manager in Bayer Pharmaceuticals, Chía, Colombia. 2 Centro…
Guillain-Barre syndrome during arboviral outbreaks in Mexico. Med Int Méx 2022; 38 (4): 820-824. https://doi.org/10.24245/mim.v38i4.4429 Luis del Carpio-Orantes Médico internista adscrito al departamento de Medicina Interna y Unidad de Cuidados Críticos, Hospital…
Benefits of folinic acid as coadjuvant therapy. Med Int Méx 2022; 38 (3): 571-585. https://doi.org/10.24245/mim.v38i3.5348 Luis Ulises Pérez-Arenas, Hugo Torres-Ortega, Maximiliano Escamilla-Zúñiga, Cristina Cota-Peimbert, María José Mares-Martínez Asociación Científica de Genética y…
Treatment against high-risk smoldering multiple myeloma. Med Int Méx 2022; 38 (3): 560-570. https://doi.org/10.24245/mim.v38i3.4236 Karla Sharon Lugo-Bautista,1 Enrique Juan Díaz-Greene,2 Federico Leopoldo Rodríguez-Weber3 1 Médico residente de la Especialidad de Medicina Interna. 2 Titular del curso…
COVID-19: prevention, diagnosis and treatment. Recommendations of a multidisciplinary group. Med Int Méx 2022; 38 (2): 288-321. https://doi.org/10.24245/mim.v38i2.7493 Federico Javier Ortiz-Ibarra,1 Jesús Abraham Simón-Campos,2 Alejandro Macías-Hernández,3 Juan Carlos Anda-Garay,4 Jesús Vázquez-Cortés,5 Jorge García-Méndez,6 Patricia Volkow-Fernández,7 Patricia Cornejo-Juárez,8 Mario González-Rivera,9 Jorge Antonio…